PillLamotrigine Extended Release
Lamotrigine
0 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it0 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Par Health USA, LLC | unknown | 3 | EXITED 2026 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 29, 2026RESOLVEDShortage resolved: Lamotrigine Tablet, Extended Release (Par Health, Inc.)
Lamotrigine Tablet, Extended Release — reported in shortage by Par Health, Inc.. Therapeutic category: Neurology.
- Apr 29, 2026SHORTAGEDrug shortage: Lamotrigine Tablet, Extended Release (Par Health, Inc.)
Lamotrigine Tablet, Extended Release — reported in shortage by Par Health, Inc.. Therapeutic category: Neurology.
- Mar 15, 2021RECALLRecall (Class II): Lamotrigine Extended-Release Tablets 250 mg 30 Tablets Rx Only NDC 49884-604-11 Manufactured by: Zhejiang Huahai Pharma…
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC